معرفی
Fredrik Piehl is Professor of Neurology at Karolinska Institutet's Department of Clinical Neuroscience, where he leads the research group 'Inflammation and neurodegeneration after neurotrauma'. His research focuses on neuroinflammatory conditions including multiple sclerosis (MS) and myasthenia gravis (MG), with emphasis on B-cell mechanisms, biomarker development, and optimizing immunotherapies. The group's clinical-translational approach combines experimental immunology, epidemiological methods, and clinical trials to improve treatment outcomes.
Research spans:
- Pathogenic B-cell/T-cell interactions in MS
- Neurodegeneration biomarkers (neurofilament light, GFAP)
- Rituximab therapy mechanisms in MS/MG
- Kynurenine pathway in viral neuroinflammation
- Real-world treatment effectiveness and safety
Recent publications demonstrate strong focus on:
- Personalized treatment algorithms using serum biomarkers
- Multi-national registry studies on disease burden
- Immunometabolic dysregulation in neurological infections
- Novel mechanisms of meningeal lymphatic function
Leads a 20+ member team including 11 PhD students investigating neuroimmunology, clinical trial design, and biomarker discovery. The group actively collaborates with international consortia and has significantly influenced MS treatment paradigms in Sweden.
